Related Experiment Video

Updated: Jul 11, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

[Cardiovascular disease as a current threat of older women. Relation to estrogens]

Arturo Zárate1, Renata Saucedo, Lourdes Basurto

  • 1Unidad de Investigación Médica de Enfemedades Endocinas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS. zaratre@att.net.mx

Ginecologia Y Obstetricia De Mexico
|September 14, 2007
PubMed

Insights

Cardiovascular disease (CVD) risk increases in women post-menopause due to hormonal shifts and inflammation. Hormone therapy

Area of Science:

  • Cardiovascular health
  • Endocrinology
  • Immunology

Context:

  • Cardiovascular disease (CVD) is a leading cause of death in women globally.
  • Menopause is linked to increased CVD risk due to metabolic and hormonal changes.
  • Declining ovarian function elevates proinflammatory cytokines, driving atherosclerosis.

Purpose:

  • To explore the relationship between menopause, inflammation, and cardiovascular disease risk in women.
  • To evaluate the potential cardioprotective effects of hormone therapy in postmenopausal women.
  • To investigate the role of inflammation in hormone therapy's impact on cardiovascular disease.

Summary:

  • Menopause-associated hormonal changes increase proinflammatory cytokines, contributing to atherosclerosis and cardiovascular disease.
  • Estrogen's cardioprotective role is suggested by observational studies, but clinical trials on hormone therapy show mixed results.
  • Inflammation is a key mechanism potentially mediating hormone therapy's effects on cardiovascular disease.

Impact:

  • Highlights the critical role of inflammation in postmenopausal cardiovascular disease.
  • Questions the universal benefit of hormone therapy for cardiovascular risk reduction in women.
  • Emphasizes the need for further research into personalized cardiovascular disease prevention strategies for women.

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration06:51

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

Published on: June 7, 2012

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...